Home > Healthcare > Medical Devices > Therapeutic Devices > Balloon Valvuloplasty Devices Market

Balloon Valvuloplasty Devices Market Size

Report ID: GMI9540
Published Date: May 2024
Report Format: PDF

Download Free Sample

Balloon Valvuloplasty Devices Market Size

Balloon valvuloplasty devices market size was valued at around USD 2.4 billion in 2023 and is estimated to grow at 4.8% CAGR from 2024 to 2032. Balloon valvuloplasty devices are medical devices used in interventional cardiology procedures to treat valvular heart diseases, particularly stenosis (narrowing) of heart valves. These devices consist of a balloon catheter system that is inserted into the heart through a blood vessel, typically the femoral artery, and navigated to the site of the diseased valve.

To get key market trends

Download Free Sample

The rising geriatric population is a significant driver for the balloon valvuloplasty devices market. For instance, according to the World Health Organization (WHO), in 2023, the number of persons aged 65 years or older worldwide is expected to double over the next three decades. The elderly population will reach 1.6 billion in 2050, accounting for more than 16% of the global population. Valvular heart disease, such as aortic stenosis and mitral stenosis, becomes more prevalent with age, particularly among the elderly population. As individuals age, their heart valves may degenerate, calcify, or develop other structural abnormalities, leading to valve stenosis or regurgitation.

Balloon Valvuloplasty Devices Market Report Attributes
Report Attribute	Details
Base Year:	2023
Balloon Valvuloplasty Devices Market Size in 2023:	USD 2.4 Billion
Forecast Period:	2024 - 2032
Forecast Period 2024 - 2032 CAGR:	4.8%
2032 Value Projection:	USD 3.6 Billion
Historical Data for:	2021 - 2023
No. of Pages:	180
Tables, Charts & Figures:	272
Segments covered:	Technology, Application, Age Group, End-use, and Region
Growth Drivers:	Increasing prevalence of valvular heart disease Rising geriatric population Growing technological advancements
Pitfalls & Challenges:	Limitations of balloon valvuloplasty Risk of complications

Learn more about the key segments shaping this market

Download Free Sample

Moreover, increasing use of heart valve devices, rising adoption of prosthetic heart valves, advancement in structural heart devices, rising healthcare expenditure globally, government initiatives and funding, and increasing education & awareness, are the factors supporting the growth of the market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Market size for balloon valvuloplasty devices was valued at USD 2.4 billion in 2023 and is estimated to grow at 4.8% CAGR from 2024 to 2032, driven by rising geriatric population.

The standard balloon product type segment in the balloon valvuloplasty devices industry is estimated to record USD 1.5 billion by the end of 2032, owing to their versatility and utility in a variety of valvuloplasty procedures.

U.S. balloon valvuloplasty devices market held a decent growth rate in 2023 and will grow at 4.4% CAGR during 2024-2032, owing to the high prevalence of valvular heart disease, such as aortic stenosis and mitral stenosis, due to an aging population and lifestyle-related risk.

Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson, and Company, Boston Scientific Corporation, Cardinal Health, Inc., Cook Medical Inc., Edwards Lifesciences Corporation, Innomed Medical Development Ltd., Jotech GmbH, and Medtronic plc among others.